Sunshield Chemicals completes rights issue, boosting equity capital

Sunshield Chemicals Limited's rights issue, which commenced on September 30, 2025, and concluded on October 24, 2025, has been successfully completed. The Rights Issue Committee, in a meeting on October 27, 2025, approved the allotment of 1,441,776 fully paid-up Rights Equity Shares. These shares, each with a face value of ₹10, were issued at a price of ₹901 per share, including a premium of ₹891 per equity share.

This allotment has led to a substantial increase in the company's paid-up equity share capital. The pre-rights issue paid-up share capital stood at 7,353,060 equity shares, amounting to ₹7,35,30,600. Following the allotment, the paid-up share capital has increased to 8,794,836 equity shares, totaling ₹8,79,48,360.

The details of this issuance align with the requirements specified under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI Master Circular dated November 11, 2024. This strategic move aims to strengthen the company's financial position and provide growth opportunities.